web analytics
6.3 C
Munich
Sunday, April 18, 2021

IgG/IgM Rapid Test Kits; the Rise of MJ Biotech (OTCMKTS: MJTV)

MJ Biotech (OTCMKTS: MJTV) is making an explosive move up the charts after the Company announced it is now selling its coronavirus IgG/IgM rapid test kits. The test kits are approved by the FDA for Emergency Use Authorizations. (EUA). The Company’s IgG/IgM rapid test kits are in stock and ready for immediate delivery and are already on sale on mjbiotech.us/our-products. While MJTV is just starting out many stocks in the coronavirus space have seen rapid gains in recent months.

As the coronavirus continues to spread around the world with the so called second wave being even worse than the first in many place the need for rapid testing has emerged as one of the biggest factors in the fight against the virus. According to a new report from HSRC called, “COVID-19 Pandemic Mitigation Products Market – 2020-2024”. the coronavirus testing market is expexcted to be worth $82 billion by 2021.

MJ Biotech (OTCMKTS: MJTV) markets and distributes unique medical sector products including diagnostics to address COVID-19. Through a variety of medical professionals, the Company seeks to offer the best in both traditional and alternative medical remedies. With a mission and commitment to promote health and wellness. MJ Biotech Inc. has acquired a rapid-immunoassay antibody COVID-19 test kit to be sold to medical professionals. .

image2On December 11 MJTK announced it has entered the Professional medical testing sector and has IN STOCK FOR IMMEDIATE DELIVERY Emergency Use Authorized COVID-19 “Coronavirus” IgG/IgM Rapid Test Kits. These Kits are very much in demand at present, and the Company anticipates an even larger demand in preparation for the Vaccines that will shortly be on the market. MJ Biotech’s Rapid Test Kits purchaser is the Medical Professional Market, not the individual consumer.

The MJ Biotech, Inc. marketing for distribution is for Commercial Healthcare Professionals and Professional Medical Purchasers only. The Company’s purchasers are laboratories, physicians, Indian Health Services, clinics, medical offices, hospitals and university health services. MJ Biotech is currently establishing an experienced Medical/Pharmaceutical Representative sales force to distribute and engage the Medical Community. The test kits are approved by the FDA for Emergency Use Authorizations. (EUA)

To Find out the inside Scoop on MJTV Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

MJTV

The Company is led by CEO Maxine Pierson, a high level executive banker who created the first SBA EXIM Bank City State relationship. Ms. Pierson was the featured speaker to promote business opportunities for the SBA throughout South Florida- including Broward County and worked with Palm Beach State college and the SBA to create a new Business Center on the Boca Raton FL Campus. Ms. Pierson was the Strategic Business Institute Director of Marketing and was nominated and awarded the Bilingual Fortune 500 “go to” PR Executive.  She is the lead Computer Project Manager for the State of MN Human Services Department. Ms. Pierson is also a Member of the Chamber of Commerce of the United States of America, Executive Vice President-Mergers & Acquisitions at GDT Tek, Inc., a Member of Center for Nonprofit Excellence, a Member of Palm Beach Round Table, Inc.

Dr. Christopher D. Krause, Ph.D., heads the Company’s Scientific Advisory Board. Dr. Krause has been focused on the genetic and evolutionary biology of interferon proteins and genes in vertebrates, and on publishing methods that allow measuring CFA in cells under difficult situations. Most recently he was focused on developing a technology called confocal fluorescence spectroscopy (CFS) that allows biophysical analysis of protein complexes to be done in intact cells and in real time

https://twitter.com/karmelskies007/status/1338223343644909569

 

For More on MJTV Subscribe Right Now!

MJTV is making an explosive move up the charts after the Company announced it is now selling its coronavirus IgG/IgM rapid test kits. The test kits are approved by the FDA for Emergency Use Authorizations. (EUA). The Company’s IgG/IgM rapid test kits are in stock and ready for immediate delivery and are already on sale on mjbiotech.us/our-products. As the coronavirus continues to spread around the world with the so called second wave being even worse than the first in many place the need for rapid testing has emerged as one of the biggest factors in the fight against the virus. While MJTV is just starting out many stocks in the coronavirus space have seen rapid gains in recent months. We will be updating on MJTV on a daily basis so make sure you are subscribed to microcapdaily.com so you know what is going on with MJTV.

Sign Up now for our 100% FREE Penny Stock Newsletter

Disclosure: we hold no position in MJTV either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.